Question 1

What is the catalog number for 3-Hydroxy-4-nitrobenzyl pivalate?

Accepted Answer

The catalog number for 3-Hydroxy-4-nitrobenzyl pivalate is OR84068.

Question 2

What sizes are available for 3-Hydroxy-4-nitrobenzyl pivalate?

Accepted Answer

3-Hydroxy-4-nitrobenzyl pivalate is available in the following size(s): 100 mg, 250 mg, 1 g.

Question 3

How many pack sizes does 3-Hydroxy-4-nitrobenzyl pivalate come in?

Accepted Answer

3-Hydroxy-4-nitrobenzyl pivalate is available in 3 different pack sizes.

Question 4

Is 3-Hydroxy-4-nitrobenzyl pivalate in stock?

Accepted Answer

3-Hydroxy-4-nitrobenzyl pivalate is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 6

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

Question 7

What is the recommended incubation time for this antibody?

Accepted Answer

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.

3-Hydroxy-4-nitrobenzyl pivalate

Product Specifications

CAS Number

MDL Number

Purity

Smiles

Available Sizes

Frequently Asked Questions

Explore Other Products

Secretogranin 3 (SCG3) (NM_013243) Human Over-expression Lysate

PTH / Parathyroid Hormone (N-Terminal) (PTH/1173), CF594 conjugate, 0.1mg/mL

SPACA6 Human qPCR Primer Pair (NM_207324)

USP40 Mouse Monoclonal Antibody [Clone ID: OTI8F8]

ALAS1 Rabbit Monoclonal Antibody [Clone ID: 23GB3190]

SATB1 Human Gene Knockout Kit (CRISPR)